Huntington’s disease

Recent articles

Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read

Explore more from The Transmitter

Speech bubbles progress from light- to dark- colored.

Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence

Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.

By Emily Singer
28 August 2026 | 5 min read
Stages of neurodegeneration: Neurofibrillary tangles at different stages of neurodegeneration are labeled with phosphorylated tau antibodies (green and blue).

Reimagining Mexico’s brain bank

Since Alzheimer’s disease researcher José Luna-Muñoz assumed leadership of the facility—Latin America’s oldest—in 2011, he has been acquiring additional tissue types and is working to expand donor recruitment to rural areas.

By Alejandra Manjarrez
28 August 2026 | 7 min read

Revealing how crabs make their escape

Houdini-like Neohelice granulata offers a rare opportunity to record intracellularly from awake, behaving animals.

By Natalia Mesa
28 August 2026 | 0 min watch